COVID-19 Still Dampens Neurocrine Revenues Despite Industry’s Q3 Uptick
A Pair Of Clinical Holds Hinders The Pipeline
The pandemic has hit psychiatry offices hard, and the company’s management said it anticipates flat sequential revenues in Q4.
The pandemic has hit psychiatry offices hard, and the company’s management said it anticipates flat sequential revenues in Q4.